Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management

This publication has 69 references indexed in Scilit:

• Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era
  Journal of Hepatology, 2005
• Longitudinal Effect of Antiretroviral Therapy on Markers of Hepatic Toxicity: Impact of Hepatitis C Coinfection
  Clinical Infectious Diseases, 2004
• Short Communication: Liver Toxicity of Lopinavir-Containing Regimens in HIV-Infected Patients with or without Hepatitis C Coinfection
  AIDS Research and Human Retroviruses, 2004
• Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C
  AIDS, 2004
• Incidence of Liver Injury After Beginning Antiretroviral Therapy with Efavirenz or Nevirapine
  HIV Research & Clinical Practice, 2003
• A Cohort Study of Nevirapine Tolerance in Clinical Practice: French Aquitaine Cohort, 1997–1999
  Clinical Infectious Diseases, 2002
• Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections
  Hepatology, 2002
• Symptomatic Lactic Acidosis in Hospitalized Antiretroviral‐Treated Patients with Human Immunodeficiency Virus Infection: A Report of 12 Cases
  Clinical Infectious Diseases, 2001
• Drug–Induced Liver Injury: Mechanisms and Test Systems
  Hepatology, 2001
• Risk Factors for Hepatotoxicity in HIV-1--Infected Patients Receiving Ritonavir and Saquinavir with or without Stavudine
  Clinical Infectious Diseases, 2000